Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Van Assche

Showing results (81-90 of 287) with videos related to

Pageof 29
Sort By:
Scandinavian Journal of Gastroenterology|May 21, 2019
Short Health Scale: a valid and reliable measure of quality of life in Dutch speaking patients with inflammatory bowel diseaseSofie Coenen, Ellen Weyts, Patricia Geens, et al.
Gut|April 29, 2017
Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trialThomas Van Stappen, Niels Vande Casteele, Gert Van Assche, et al.
British Journal of Clinical Pharmacology|January 12, 2019
Optimising infliximab induction dosing for patients with ulcerative colitisErwin Dreesen, Ruben Faelens, Gert Van Assche, et al.
Inflammatory Bowel Diseases|December 22, 2016
A Pooled Analysis of Efficacy, Safety, and Long-term Outcome of Endoscopic Balloon Dilation Therapy for Patients with Stricturing Crohn's DiseaseDominik Bettenworth, Anders Gustavsson, Ashish Atreja, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 9, 2010
Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imagingKonstantinos Karmiris, Didier Bielen, Dirk Vanbeckevoort, et al.
Inflammatory Bowel Diseases|January 8, 2019
Vedolizumab in Combination With Corticosteroids for Induction Therapy in Crohn's Disease: A Post Hoc Analysis of GEMINI 2 and 3Bruce E Sands, Gert Van Assche, David Tudor, et al.
Journal of Crohn'S & Colitis|September 22, 2018
Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel DiseaseKaren van Hoeve, Erwin Dreesen, Ilse Hoffman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2006
Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitisDavid N Moskovitz, Gert Van Assche, Benedikte Maenhout, et al.
European Journal of Gastroenterology & Hepatology|October 30, 2015
Thromboembolism as an important complication of inflammatory bowel diseaseLize Bollen, Niels Vande Casteele, Vera Ballet, et al.
Therapeutic Drug Monitoring|January 12, 2019
Efficacy, Pharmacokinetics, and Immunogenicity is Not Affected by Switching From Infliximab Originator to a Biosimilar in Pediatric Patients With Inflammatory Bowel DiseaseKaren van Hoeve, Erwin Dreesen, Ilse Hoffman, et al.
Pageof 29

Showing results (81-90 of 287) with videos related to

Sort By:
Pageof 29
Scandinavian Journal of Gastroenterology|May 21, 2019
Short Health Scale: a valid and reliable measure of quality of life in Dutch speaking patients with inflammatory bowel diseaseSofie Coenen, Ellen Weyts, Patricia Geens, et al.
Gut|April 29, 2017
Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trialThomas Van Stappen, Niels Vande Casteele, Gert Van Assche, et al.
British Journal of Clinical Pharmacology|January 12, 2019
Optimising infliximab induction dosing for patients with ulcerative colitisErwin Dreesen, Ruben Faelens, Gert Van Assche, et al.
Inflammatory Bowel Diseases|December 22, 2016
A Pooled Analysis of Efficacy, Safety, and Long-term Outcome of Endoscopic Balloon Dilation Therapy for Patients with Stricturing Crohn's DiseaseDominik Bettenworth, Anders Gustavsson, Ashish Atreja, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 9, 2010
Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imagingKonstantinos Karmiris, Didier Bielen, Dirk Vanbeckevoort, et al.
Inflammatory Bowel Diseases|January 8, 2019
Vedolizumab in Combination With Corticosteroids for Induction Therapy in Crohn's Disease: A Post Hoc Analysis of GEMINI 2 and 3Bruce E Sands, Gert Van Assche, David Tudor, et al.
Journal of Crohn'S & Colitis|September 22, 2018
Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel DiseaseKaren van Hoeve, Erwin Dreesen, Ilse Hoffman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2006
Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitisDavid N Moskovitz, Gert Van Assche, Benedikte Maenhout, et al.
European Journal of Gastroenterology & Hepatology|October 30, 2015
Thromboembolism as an important complication of inflammatory bowel diseaseLize Bollen, Niels Vande Casteele, Vera Ballet, et al.
Therapeutic Drug Monitoring|January 12, 2019
Efficacy, Pharmacokinetics, and Immunogenicity is Not Affected by Switching From Infliximab Originator to a Biosimilar in Pediatric Patients With Inflammatory Bowel DiseaseKaren van Hoeve, Erwin Dreesen, Ilse Hoffman, et al.
Pageof 29